María Isabel
Loza García
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (9)
2021
-
Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas
Biomedicine and Pharmacotherapy, Vol. 140
2020
-
Essential role of the C148–C227 disulphide bridge in the human 5-HT2A homodimeric receptor
Biochemical Pharmacology, Vol. 177
2019
-
Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia
EBioMedicine, Vol. 39, pp. 118-131
2018
-
Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke
Annals of Neurology, Vol. 84, Núm. 2, pp. 260-273
2016
-
A novel mechanism of neuroprotection: Blood glutamate grabber
Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 2, pp. 292-301
2012
2010
-
Phe369(7.38) at human 5-HT 7 receptors confers interspecies selectivity to antagonists and partial agonists
British Journal of Pharmacology, Vol. 159, Núm. 5, pp. 1069-1081
2009
-
Identification of novel scaffolds from an original chemical library as potential antipsychotics
QSAR and Combinatorial Science
2007
-
Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population
Schizophrenia Research, Vol. 90, Núm. 1-3, pp. 123-129